COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses

Background: Vaccine hesitancy represents one of the major global health issues around the world. We examined the perception, attitude, perceived barriers and facilitation measures of receiving the COVID-19 vaccine in a Chinese population with free vaccine choices (Sinovac [Coronavac] vs. BioNTech/Fo...

Full description

Bibliographic Details
Main Authors: Martin C. S. Wong, Eliza L. Y. Wong, Annie W. L. Cheung, Junjie Huang, Christopher K. C. Lai, Eng Kiong Yeoh, Paul K. S. Chan
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/11/1250
_version_ 1797508337427808256
author Martin C. S. Wong
Eliza L. Y. Wong
Annie W. L. Cheung
Junjie Huang
Christopher K. C. Lai
Eng Kiong Yeoh
Paul K. S. Chan
author_facet Martin C. S. Wong
Eliza L. Y. Wong
Annie W. L. Cheung
Junjie Huang
Christopher K. C. Lai
Eng Kiong Yeoh
Paul K. S. Chan
author_sort Martin C. S. Wong
collection DOAJ
description Background: Vaccine hesitancy represents one of the major global health issues around the world. We examined the perception, attitude, perceived barriers and facilitation measures of receiving the COVID-19 vaccine in a Chinese population with free vaccine choices (Sinovac [Coronavac] vs. BioNTech/Fosun [Comirnaty]) and adequate doses. Method: We conducted a random telephone survey of the general population in 1195 subjects aged 18 years or above from 23 April 2021 to 8 May 2021 after two months of vaccine rollout. A descriptive analysis of the levels of enabling factors, obstacles and perception of COVID-19 vaccination was conducted using ANOVA and Chi-square tests for trend. Results: Only 10.1% and 13.5% had received one and two COVID-19 vaccine doses, respectively. Among those who had not received any COVID-19 vaccine (75.4%), only 25.1% expressed their intention to receive in the coming 6 months. The barriers with the highest scores included “having heard of cases with serious adverse events or death after vaccination” (score: 8.17 out 10, 95% C.I. 7.99, 8.35), “lack of confidence on governmental recommendations” (7.69, 95% C.I. 7.47, 7.91), and “waiting for a better vaccine” (7.29, 95% C.I. 7.07, 7.52). The highest score for the impact of various incentives for vaccination was for “vaccine passports for overseas travel” (4.44, 95% C.I. 4.18, 4.71). Conclusions: Vaccine hesitancy is commonly observed in this Chinese population despite adequate provision of vaccine doses and choices. No single incentive is strong enough to promote vaccination, and multiple facilitation measures for different groups of population are needed to encourage vaccine uptake. Active clarification and promotion by medical professionals together with a variety of incentives are needed to drive vaccine uptake.
first_indexed 2024-03-10T05:00:41Z
format Article
id doaj.art-ea5d7dbb70cb431aaa70fdd01ef5d307
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T05:00:41Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-ea5d7dbb70cb431aaa70fdd01ef5d3072023-11-23T01:51:43ZengMDPI AGVaccines2076-393X2021-10-01911125010.3390/vaccines9111250COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient DosesMartin C. S. Wong0Eliza L. Y. Wong1Annie W. L. Cheung2Junjie Huang3Christopher K. C. Lai4Eng Kiong Yeoh5Paul K. S. Chan6JC School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong, Hong KongCentre for Health Systems & Policy Research, JC School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong, Hong KongCentre for Health Systems & Policy Research, JC School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong, Hong KongJC School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong, Hong KongDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong KongCentre for Health Systems & Policy Research, JC School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong, Hong KongDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong KongBackground: Vaccine hesitancy represents one of the major global health issues around the world. We examined the perception, attitude, perceived barriers and facilitation measures of receiving the COVID-19 vaccine in a Chinese population with free vaccine choices (Sinovac [Coronavac] vs. BioNTech/Fosun [Comirnaty]) and adequate doses. Method: We conducted a random telephone survey of the general population in 1195 subjects aged 18 years or above from 23 April 2021 to 8 May 2021 after two months of vaccine rollout. A descriptive analysis of the levels of enabling factors, obstacles and perception of COVID-19 vaccination was conducted using ANOVA and Chi-square tests for trend. Results: Only 10.1% and 13.5% had received one and two COVID-19 vaccine doses, respectively. Among those who had not received any COVID-19 vaccine (75.4%), only 25.1% expressed their intention to receive in the coming 6 months. The barriers with the highest scores included “having heard of cases with serious adverse events or death after vaccination” (score: 8.17 out 10, 95% C.I. 7.99, 8.35), “lack of confidence on governmental recommendations” (7.69, 95% C.I. 7.47, 7.91), and “waiting for a better vaccine” (7.29, 95% C.I. 7.07, 7.52). The highest score for the impact of various incentives for vaccination was for “vaccine passports for overseas travel” (4.44, 95% C.I. 4.18, 4.71). Conclusions: Vaccine hesitancy is commonly observed in this Chinese population despite adequate provision of vaccine doses and choices. No single incentive is strong enough to promote vaccination, and multiple facilitation measures for different groups of population are needed to encourage vaccine uptake. Active clarification and promotion by medical professionals together with a variety of incentives are needed to drive vaccine uptake.https://www.mdpi.com/2076-393X/9/11/1250COVID-19vaccine hesitancyvaccine choicebarriersincentivescompulsory vaccination
spellingShingle Martin C. S. Wong
Eliza L. Y. Wong
Annie W. L. Cheung
Junjie Huang
Christopher K. C. Lai
Eng Kiong Yeoh
Paul K. S. Chan
COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
Vaccines
COVID-19
vaccine hesitancy
vaccine choice
barriers
incentives
compulsory vaccination
title COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_full COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_fullStr COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_full_unstemmed COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_short COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_sort covid 19 vaccine hesitancy in a city with free choice and sufficient doses
topic COVID-19
vaccine hesitancy
vaccine choice
barriers
incentives
compulsory vaccination
url https://www.mdpi.com/2076-393X/9/11/1250
work_keys_str_mv AT martincswong covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses
AT elizalywong covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses
AT anniewlcheung covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses
AT junjiehuang covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses
AT christopherkclai covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses
AT engkiongyeoh covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses
AT paulkschan covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses